TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy

TIGIT is a recently identified coinhibitory receptor that is upregulated in the setting of cancer and functionally contributes to the impairment of antitumor immunity. However, its role during sepsis is unknown. Because patients with cancer are 10 times more likely to die of sepsis than previously h...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JCI Insight
Huvudupphovsmän: Zhang, Wenxiao, Anyalebechi, Jerome C., Ramonell, Kimberly M., Chen, Ching-wen, Xie, Jianfeng, Liang, Zhe, Chihade, Deena B., Otani, Shunsuke, Coopersmith, Craig M., Ford, Mandy L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Clinical Investigation 2021
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262279/
https://ncbi.nlm.nih.gov/pubmed/34100383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.139823
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk